Rafarma pharmaceutical updates: agreements with Shri Lanka pharmaceutical company Kelun Lifesciences (Pvt) Ltd and El Salvador University
11. Dezember 2023 09:30 ET
|
Rafarma Pharmaceuticals Inc.
Sheridan, Wyoming, USA, Dec. 11, 2023 (GLOBE NEWSWIRE) -- Rafarma Pharmaceuticals (OTC: RAFA) - We are pleased to announce that Rapharma and its CEO Raivo Unt have entered into a preliminary agreement...
Rafarma Pharmaceutical news update
30. November 2023 09:30 ET
|
Rafarma Pharmaceuticals Inc.
Russia, Moscow, Nov. 30, 2023 (GLOBE NEWSWIRE) -- Rafarma Pharmaceuticals (OTC: RAFA). The Company is pleased to announce that it has completed the restructuring, accounting and balance sheet...
Rafarma Pharmaceuticals strengthens its position in Central Asia
29. April 2022 09:15 ET
|
RAFARMA PHARMACEUTICALS INC
Nicosia, Cyprus, April 29, 2022 (GLOBE NEWSWIRE) -- Representatives of Rafarma Pharmaceuticals, Inc. (OTC: RAFA) visited Uzbekistan and discussed the prospects for the company's development in the...
Rafarma’s Slavich Noya Technology Division Expands Printing Production
07. Februar 2022 09:15 ET
|
RAFARMA PHARMACEUTICALS INC
Nicosia, Cyprus, Feb. 07, 2022 (GLOBE NEWSWIRE) -- Rafarma Pharmaceuticals, Inc. OTC:(RAFA) Slavich Noya Technology, part of the Rafarma Pharmaceuticals group of companies, is expanding its...
RAFA Enters into Negotiations with JINR for Ultra-Cutting Edge Nuclear Research
21. Dezember 2021 10:50 ET
|
RAFARMA PHARMACEUTICALS INC
Nicosia, Cyprus, Dec. 21, 2021 (GLOBE NEWSWIRE) -- Rafarma Pharmaceuticals, Inc. OTC:(RAFA) is currently negotiating with the Joint Institute for Nuclear Research (JINR), an international...
Explosive Growth Launches Kraspharma Into REMEDIUM TOP-5
19. November 2021 09:25 ET
|
RAFARMA PHARMACEUTICALS INC
Nicosia, Cyprus, Nov. 19, 2021 (GLOBE NEWSWIRE) -- Rafarma Pharmaceuticals, Inc. OTC:(RAFA) reports that PJSC Kraspharma at the end of 2020 entered the TOP-5 of the most dynamic and largest...
Status Update to Shareholders from Rafarma Pharmaceuticals, Inc.
08. November 2021 10:43 ET
|
RAFARMA PHARMACEUTICALS INC
Nicosia, Cyprus, Nov. 08, 2021 (GLOBE NEWSWIRE) -- Rafarma Pharmaceuticals, Inc. OTC:(RAFA) provides the following update to shareholders: The company is continuing its PCAOB auditing process, and,...
Rafarma Enters Negotiations With Leading Global Producer of Precious Metals to Localize Production of Platinum-Based Cancer Drugs
19. August 2021 10:25 ET
|
RAFARMA PHARMACEUTICALS INC
Nicosia, Cyprus, Aug. 19, 2021 (GLOBE NEWSWIRE) -- Rafarma Pharmaceuticals, Inc. OTC:(RAFA) and one of the world's largest producers of precious metals, Krastsvetmet (Russia, Krasnoyarsk), discussed...
Rafarma Signs Trilateral Investment Agreement Officially Launching Tashkent Pharmaceutical Plant Build
30. Juli 2021 09:49 ET
|
RAFARMA PHARMACEUTICALS INC
Nicosia, Cyprus, July 30, 2021 (GLOBE NEWSWIRE) -- Rafarma Pharmaceuticals, Inc. OTC:(RAFA) The scientific and technical council of the Agency for the Development of the Pharmaceutical Industry of...
Rafarma’s Global Pharmaceutical Strategy At A Glance
18. Mai 2021 08:53 ET
|
RAFARMA PHARMACEUTICALS INC
Nicosia, Cyprus, May 18, 2021 (GLOBE NEWSWIRE) -- Rafarma Pharmaceuticals, Inc. OTC:(RAFA) is an international biotechnological and pharmaceutical company that combines research centers and modern...